Identification of owl monkey CD4 receptors broadly compatible with early-stage HIV-1 isolates

Journal of Virology

Volumn 89, Issue 16, 2015, Pages 8611-8622

  Meyerson, Nicholas R ^a   Sharma, Amit ^b   Wilkerson, Gregory K ^c   Overbaugh, Julie ^b   Sawyer, Sara L ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; CD4 RECEPTOR; UNCLASSIFIED DRUG; VIRUS RECEPTOR; CD4 ANTIGEN; PRIMER DNA;

ALLELE; AOTUS; AOTUS AZARAE; AOTUS NANCYMAAE; ARTICLE; CLADISTICS; CONTROLLED STUDY; FEMALE; GENETIC CODE; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; SPECIES DIFFERENCE; VIRUS ISOLATION; ANIMAL; AOTIDAE; DNA SEQUENCE; FLOW CYTOMETRY; GENETIC SELECTION; GENETIC VARIATION; GENETICS; GENOTYPE; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS;

ANIMALIA; AOTUS AZARAI; AOTUS NANCYMAAE; AOTUS TRIVIRGATUS; AOTUS VOCIFERANS; HUMAN IMMUNODEFICIENCY VIRUS 1; PLATYRRHINI; PRIMATES;

ANIMALS; ANTIGENS, CD4; AOTIDAE; BASE SEQUENCE; DNA PRIMERS; EVOLUTION, MOLECULAR; FLOW CYTOMETRY; GENETIC VARIATION; GENOTYPE; HIV-1; MOLECULAR SEQUENCE DATA; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY;

EID: 84938153605     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00890-15     Document Type: Article

References (51)

1. Huang J, Meyer C, Zhu C. 2012. T cell antigen recognition at the cell membrane. Mol Immunol 52:155-164. http://dx.doi.org/10.1016/j.molimm.2012.05.004.
2. Ortiz M, Guex N, Patin E, Martin O, Xenarios I, Ciuffi A, Quintana-Murci L, Telenti A. 2009. Evolutionary trajectories of primate genes involved in HIV pathogenesis. Mol Biol Evol 26:2865-2875. http://dx.doi.org/10.1093/molbev/msp197.
3. Meyerson NR, Rowley PA, Swan CH, Le DT, Wilkerson GK, Sawyer SL. 2014. Positive selection of primate genes that promote HIV-1 replication. Virology 454-455:291-298.
4. Zhang ZD, Weinstock G, Gerstein M. 2008. Rapid evolution by positive Darwinian selection in T-cell antigenCD4in primates. J Mol Evol 66:446-456. http://dx.doi.org/10.1007/s00239-008-9097-1.
5. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648-659. http://dx.doi.org/10.1038/31405.
6. Meyerson NR, Sawyer SL. 2011. Two-stepping through time: mammals and viruses. 6. Trends Microbiol 19:286-294. http://dx.doi.org/10.1016/j.tim.2011.03.006.
7. Cenci A, D'Avenio G, Tavoschi L, Chiappi M, Becattini S, Narino MDP, Picconi O, Bernasconi D, Fanales-Belasio E, Vardas E, Sukati H, Presti Lo A, Ciccozzi M, Monini P, Ensoli B, Grigioni M, Buttò S. 2014. Molecular characterization of HIV-1 subtypeCgp-120 regions potentially involved in virus adaptive mechanisms. PLoS One 9:e95183. http://dx.doi.org/10.1371/journal.pone.0095183.
8. Yamaguchi-Kabata Y, Gojobori T. 2000. Reevaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes. J Virol 74: 4335-4350. http://dx.doi.org/10.1128/JVI.74.9.4335-4350.2000.
9. Yang Z. 2001. Maximum likelihood analysis of adaptive evolution in HIV-1 gp120 env gene. Pac Symp Biocomput 21:226-237.
10. Hatziioannou T, Evans DT. 2012. Animal models for HIV/AIDS research. Nat Rev Microbiol 10:852-867. http://dx.doi.org/10.1038/nrmicro2911.
11. Harris RS, Hultquist JF, Evans DT. 2012. The restriction factors of human immunodeficiency virus. J Biol Chem 287:40875-40883. http://dx.doi.org/10.1074/jbc.R112.416925.
12. Blanco-Melo D, Venkatesh S, Bieniasz PD. 2012. Intrinsic cellular defenses against human immunodeficiency viruses. Immunity 37:399-411. http://dx.doi.org/10.1016/j.immuni.2012.08.013.
13. Hessell AJ, Haigwood NL. 2015. Animal models in HIV-1 protection and therapy. Curr Opin HIV AIDS 10:170-176. http://dx.doi.org/10.1097/COH.0000000000000152.
14. Humes D, Emery S, Laws E, Overbaugh J. 2012. A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection. J Virol 86:12472-12483. http://dx.doi.org/10.1128/JVI.02176-12.
15. Fomsgaard A, Johnson PR, Nielsen C, Novembre FJ, Hansen J, Goldstein S, Hirsch VM. 1995. Receptor function of CD4 structures from African green monkey and pig-tail macaque for simian immunodeficiency virus, SIVsm, SIVagm, and human immunodeficiency virus type-1. Viral Immunol 8:121-133.
16. Wong SK, Connole M, Sullivan JS, Choe H, Carville A, Farzan M. 2009. A New World primate deficient in tetherin-mediated restriction of human immunodeficiency virus type 1. J Virol 83:8771-8780. http://dx.doi.org/10.1128/JVI.00112-09.
17. LaBonte JA, Babcock GJ, Patel T, Sodroski J. 2002. Blockade of HIV-1 infection of New World monkey cells occurs primarily at the stage of virus entry. J Exp Med 196:431-445. http://dx.doi.org/10.1084/jem.20020468.
18. Karlsson GB, Halloran M, Li J, Park IW, Gomila R, Reimann KA, Axthelm MK, Iliff SA, Letvin NL, Sodroski J. 1997. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J Virol 71:4218-4225.
19. Boyd DF, Peterson D, Haggarty BS, Jordan APO, Hogan MJ, Goo L, Hoxie JA, Overbaugh J. 2015. Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer. J Virol 89:894-907. http://dx.doi.org/10.1128/JVI.02680-14.
20. Del Prete GQ, Ailers B, Moldt B, Keele BF, Estes JD, Rodriguez A, Sampias M, Oswald K, Fast R, Trubey CM, Chertova E, Smedley J, LaBranche CC, Montefiori DC, Burton DR, Shaw GM, Markowitz M, Piatak M, Jr, Kewal Ramani VN, Bieniasz PD, Lifson JD, Hatziioannou T. 2014. Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins. Cell Host Microbe 16:412-418. http://dx.doi.org/10.1016/j.chom.2014.08.003.
21. Humes D, Overbaugh J. 2011. Adaptation of subtype A human immunodeficiency virus type 1 envelope to pig-tailed macaque cells. J Virol 85:4409-4420. http://dx.doi.org/10.1128/JVI.02244-10.
22. Puffer BA, Pohlmann S, Edinger AL, Carlin D, Sanchez MD, Reitter J, Watry DD, Fox HS, Desrosiers RC, Doms RW. 2002. CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity. J Virol 76:2595-2605. http://dx.doi.org/10.1128/JVI.76.6.2595-2605.2002.
23. Long EM, Rainwater SMJ, Lavreys L, Mandaliya K, Overbaugh J. 2002. HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus. 8. AIDS Res Hum Retroviruses 18:567-576. http://dx.doi.org/10.1089/088922202753747914.
24. Blish CA, Jalalian-Lechak Z, Rainwater S, Nguyen M-A, Dogan OC, Overbaugh J. 2009. Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1. J Virol 83:7783-7788. http://dx.doi.org/10.1128/JVI.00673-09.
25. Rainwater SMJ, Wu X, Nduati R, Nedellec R, Mosier D, John-Stewart G, Mbori-Ngacha D, Overbaugh J. 2007. Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding. Curr HIV Res 5:189-197. http://dx.doi.org/10.2174/157016207780076986.
26. Wu X, Parast AB, Richardson BA, Nduati R, John-Stewart G, Mbori-Ngacha D, Rainwater SMJ, Overbaugh J. 2006. Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J Virol 80:835-844. http://dx.doi.org/10.1128/JVI.80.2.835-844.2006.
27. Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, Voss G, Goepfert P, Gilbert P, Greene KM, Bilska M, Kothe DL, Salazar-Gonzalez JF, Wei X, Decker JM, Hahn BH, Montefiori DC. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 79:10108-10125. http://dx.doi.org/10.1128/JVI.79.16.10108-10125.2005.
28. Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, Robinson JE, Decker JM, Li Y, Salazar MG, Polonis VR, Mlisana K, Karim SA, Hong K, Greene KM, Bilska M, Zhou J, Allen S, Chomba E, Mulenga J, Vwalika C, Gao F, Zhang M, Korber BTM, Hunter E, Hahn BH, Montefiori DC. 2006. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J Virol 80:11776-11790. http://dx.doi.org/10.1128/JVI.01730-06.
29. Mirzabekov T, Bannert N, Farzan M, Hofmann W, Kolchinsky P, Wu L, Wyatt R, Sodroski J. 1999. Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor. J Biol Chem 274:28745-28750. http://dx.doi.org/10.1074/jbc.274.40.28745.
30. Yang Z. 2007. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24:1586-1591. http://dx.doi.org/10.1093/molbev/msm088.
31. Karolchik D, Baertsch R, Diekhans M, Furey T, Hinrichs A, Lu Y, Roskin K, Schwartz M, Sugnet C, Thomas D, Weber R, Haussler D, Kent W. 2003. The UCSC Genome Browser Database. Nucleic Acids Res 31:51-54. http://dx.doi.org/10.1093/nar/gkg129.
32. Sironi M, Cagliani R, Forni D, Clerici M. 2015. Evolutionary insights into host-pathogen interactions from mammalian sequence data. Nat Rev Genet 16:224-236. http://dx.doi.org/10.1038/nrg3905.
33. Sayah DM, Sokolskaja E, Berthoux L, Luban J. 2004. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430:569-573. http://dx.doi.org/10.1038/nature02777.
34. Nisole S, Lynch C, Stoye JP, Yap MW. 2004. A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci U S A 101:13324-13328. http://dx.doi.org/10.1073/pnas.0404640101.
35. Ribeiro IP, Menezes AN, Moreira MAM, Bonvicino CR, Seuánez HN, Soares MA. 2005. Evolution of cyclophilin A and TRIMCyp retrotransposition in New World primates. J Virol 79:14998-15003. http://dx.doi.org/10.1128/JVI.79.23.14998-15003.2005.
36. Pacheco B, Basmaciogullari S, LaBonte JA, Xiang S-H, Sodroski J. 2008. Adaptation of the human immunodeficiency virus type 1 envelope glycoproteins to New World monkey receptors. J Virol 82:346-357. http://dx.doi.org/10.1128/JVI.01299-07.
37. Fomsgaard A, Müller-Trutwin MC, Diop O, Hansen J, Mathiot C, Corbet S, Barré-Sinoussi F, Allan JS. 1997. Relation between phylogeny of African green monkey CD4 genes and their respective simian immunodeficiency virus genes. J Med Primatol 26:120-128. http://dx.doi.org/10.1111/j.1600-0684.1997.tb00043.x.
38. Hvilsom C, Carlsen F, Siegismund HR, Corbet S, Nerrienet E, Fomsgaard A. 2008. Genetic subspecies diversity of the chimpanzee CD4 virusreceptor gene. Genomics 92:322-328. http://dx.doi.org/10.1016/j.ygeno.2008.07.003.
39. Hofmann W, Schubert D, LaBonte J, Munson L, Gibson S, Scammell J, Ferrigno P, Sodroski J. 1999. Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol 73:10020-10028.
40. Diaz-Griffero F, Vandegraaff N, Li Y, McGee-Estrada K, Stremlau M, Welikala S, Si Z, Engelman A, Sodroski J. 2006. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 351:404-419. http://dx.doi.org/10.1016/j.virol.2006.03.023.
41. Ward JM, Vallender EJ. 2012. The resurgence and genetic implications of New World primates in biomedical research. Trends Genet 28:586-591. http://dx.doi.org/10.1016/j.tig.2012.09.003.
42. Fox JG, Anderson LC, Loew FM, Quimby FW. 2002. Laboratory animal medicine. Academic Press, New York, NY.
43. Krupp A, McCarthy KR, Ooms M, Letko M, Morgan JS, Simon V, Johnson WE. 2013. APOBEC3G polymorphism as a selective barrier to cross-species transmission and emergence of pathogenic SIV and AIDS in a primate host. PLoS Pathog 9:e1003641. http://dx.doi.org/10.1371/journal.ppat.1003641.
44. Sawyer SL, Wu LI, Akey JM, Emerman M, Malik HS. 2006. Highfrequency persistence of an impaired allele of the retroviral defense gene TRIM5 in humans. Curr Biol 16:95-100. http://dx.doi.org/10.1016/j.cub.2005.11.045.
45. Duggal NK, Fu W, Akey JM, Emerman M. 2013. Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations. Virology 443:329-337. http://dx.doi.org/10.1016/j.virol.2013.05.016.
46. Compton AA, Hirsch VM, Emerman M. 2012. The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict. Cell Host Microbe 11:91-98. http://dx.doi.org/10.1016/j.chom.2011.11.010.
47. Kirmaier A, Wu F, Newman RM, Hall LR, Morgan JS, O'Connor S, Marx PA, Meythaler M, Goldstein S, Buckler-White A, Kaur A, Hirsch VM, Johnson WE. 2010. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol 8:e1000462. http://dx.doi.org/10.1371/journal.pbio.1000462.
48. OhAinle M, Kerns JA, Li MMH, Malik HS, Emerman M. 2008. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 4:249-259. http://dx.doi.org/10.1016/j.chom.2008.07.005.
49. Wang JH, Meijers R, Xiong Y, Liu JH, Sakihama T, Zhang R, Joachimiak A, Reinherz EL. 2001. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class IIMHCmolecule. Proc Natl Acad SciUSA98:10799-10804. http://dx.doi.org/10.1073/pnas.191124098.
50. Huang CC, Venturi M, Majeed S, Moore MJ, Phogat S, Zhang MY, Dimitrov DS, Hendrickson WA, Robinson J, Sodroski J, Wyatt R, Choe H, Farzan M, Kwong PD. 2004. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptorbinding site on gp120. Proc Natl Acad Sci U S A 101:2706-2711. http://dx.doi.org/10.1073/pnas.0308527100.
51. Sharp PM, Hahn BH. 2011. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med 1:a006841.